Yungjin Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Sep '13 Sep 30, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
Cash & Equivalents	4,610	2,670	6,628	-	817.85	1,110
Cash & Short-Term Investments	4,610	2,670	6,628	19,593	817.85	1,110
Cash Growth	-4.74%	-59.72%	-66.17%	2295.72%	-26.29%	-46.42%
Accounts Receivable	44,861	42,645	37,654	-	37,868	43,921
Other Receivables	-	-	-	-	78.93	84.97
Receivables	44,861	42,645	37,654	-	37,947	44,006
Inventory	35,061	29,281	25,413	-	22,919	21,029
Prepaid Expenses	664.86	24.38	36.44	-	169.05	134.64
Other Current Assets	30.38	99.87	27.05	-	23,016	23,057
Total Current Assets	85,227	74,721	69,758	-	84,868	89,336
Property, Plant & Equipment	60,707	59,272	59,896	-	46,337	46,846
Long-Term Investments	342.45	336.15	1,342	-	420.15	165.15
Other Intangible Assets	3,817	3,991	3,533	-	3,552	3,474
Long-Term Accounts Receivable	1,580	1,494	1,521	-	-	-
Long-Term Deferred Tax Assets	1,843	395.76	-	-	-	-
Other Long-Term Assets	21,734	21,741	21,736	-	2,208	2,060
Total Assets	175,251	161,951	157,787	-	137,385	141,881
Accounts Payable	22,702	22,077	18,432	-	7,984	6,577
Accrued Expenses	-	-	-	-	737.86	7,720
Short-Term Debt	17,500	15,000	18,300	-	44,603	37,543
Current Portion of Long-Term Debt	222.8	292.9	503.2	-	447.86	280.4
Current Income Taxes Payable	880.36	896.31	216.08	-	-	-
Other Current Liabilities	71.74	113.5	82.66	-	5,052	8,134
Total Current Liabilities	41,377	38,380	37,534	-	58,824	60,254
Long-Term Debt	10,336	9,625	9,036	-	2,026	2,474
Pension & Post-Retirement Benefits	22,013	20,737	19,048	-	13,348	13,142
Other Long-Term Liabilities	2,358	2,142	2,289	-	2,256	1,957
Total Liabilities	76,084	70,882	67,907	-	76,455	77,828
Common Stock	88,810	88,810	88,810	-	59,146	59,146
Additional Paid-In Capital	2,970	2,970	2,970	-	281.8	-
Retained Earnings	7,387	-711.53	-1,900	-	1,501	4,625
Comprehensive Income & Other	-	-	-	-	-	281.8
Shareholders' Equity	99,167	91,068	89,880	91,931	60,929	64,053
Total Liabilities & Equity	175,251	161,951	157,787	-	137,385	141,881
Total Debt	28,059	24,917	27,840	32,090	47,077	40,298
Net Cash (Debt)	-23,450	-22,247	-21,212	-12,496	-46,259	-39,188
Net Cash Per Share	-147.08	-123.99	-123.28	-	-391.06	-331.28
Filing Date Shares Outstanding	178.25	101.91	175.71	-	118.29	118.29
Total Common Shares Outstanding	178.25	101.91	175.71	-	118.29	118.29
Working Capital	43,850	36,341	32,224	-	26,044	29,082
Book Value Per Share	556.34	893.64	511.53	517.57	515.07	541.48
Tangible Book Value	95,350	87,078	86,347	88,491	57,378	60,579
Tangible Book Value Per Share	534.93	854.48	491.43	498.20	485.05	512.11
Land	-	-	-	-	13,748	13,806
Buildings	-	-	-	-	21,293	20,523
Machinery	-	-	-	-	47,754	48,001
Construction In Progress	-	-	-	-	850.73	729.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.